Bertek Pharmaceuticals to change name.

2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Mylan Laboratories, Inc., (MYL) is changing the name of its branded subsidiary, currently known as Bertek Pharmaceuticals, Inc., to Mylan Bertek Pharmaceuticals, Inc.

The name change of the branded subsidiary reflects Mylan's continued commitment and focus on its brand business in anticipation of the launch of two significant proprietary products.

APOKYN, according to the company the first and only therapy approved in the United States for the acute, intermittent treatment of hypomobility ("off" episodes) associated with advanced Parkinson disease, is expected to enter the market by the end of July 2004. The company …